Acute promyelocytic leukemia (APL) is a type of acute myeloid leukemia (AML). With proper treatment, the survival rates are high. APL is a relatively rare cancer, accounting for about 7–8% of adult ...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for the treatment of autoimmune ...